Related Experiment Video
Updated: Sep 12, 2025

Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction
Published on: December 3, 2017
Novel Technologies in Periprosthetic Joint Infection: Emerging Diagnostics
Matthew L Magruder1, Nathanael D Heckmann2, Jay R Lieberman2
1Department of Orthopaedic Surgery, Maimonides Medical Center, Brooklyn, New York.
Novel diagnostic tools like pH sensors and calprotectin assays offer faster, more accurate detection of periprosthetic joint infection (PJI) after total joint arthroplasty (TJA). These methods improve patient outcomes by enabling earlier PJI diagnosis and treatment.
Area of Science:
- Orthopedic Surgery
- Infectious Diseases
- Biomarker Discovery
- Diagnostic Technologies
Background:
- Periprosthetic joint infection (PJI) is a significant complication of total joint arthroplasty (TJA), leading to high morbidity and implant failure.
- Current diagnostic methods for PJI, such as synovial fluid analysis and cultures, have limitations in sensitivity and specificity, especially for culture-negative cases.
- There is a critical need for advanced diagnostic technologies for rapid and reliable PJI detection.
Purpose of the Study:
- To review and explore emerging diagnostic strategies for periprosthetic joint infection (PJI).
- To highlight novel technologies that offer improved accuracy and speed in PJI diagnosis.
- To discuss the potential impact of these innovations on patient outcomes and prosthetic longevity.
Main Methods:
- Review of emerging diagnostic strategies including real-time intra-articular pH monitoring (e.g., X-ray-based sensors, XELCI).
- Evaluation of urinary peptide biomarkers for systemic inflammatory response detection.
- Assessment of multiomics techniques (transcriptomics, proteomics, immune cell profiling) and advanced synovial fluid assays, focusing on calprotectin.
Main Results:
- Implantable pH sensors and XELCI enable noninvasive, early detection of synovial environment changes indicative of infection.
- Urinary peptide biomarkers offer a noninvasive method to reflect systemic inflammation associated with PJI.
- Synovial calprotectin, detected via lateral flow assay, shows high sensitivity and specificity for differentiating PJI from aseptic failures, serving as a point-of-care tool.
Conclusions:
- Emerging diagnostic technologies, including pH monitoring, urinary biomarkers, multiomics, and synovial calprotectin assays, show promise for revolutionizing PJI detection.
- These novel methods have the potential to reduce diagnostic delays and the need for invasive procedures.
- Further large-scale clinical validation is necessary to establish these innovations as standard-of-care for improved patient outcomes and prosthetic joint survival.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Endocarditis III: Medical Management
Endocarditis I: Introduction
MALDI-TOF Mass Spectrometry
Matrix-assisted laser desorption ionization (MALDI) is a commonly...
Bacterial Signaling

